Thursday May 25th 2017

Archive for October, 2016

Improve Kidney Function With IV Laser Treatment

Improve Kidney Function With IV Laser Treatment

If you're one of the more than 20 million Americans who suffer from chronic kidney disease (CKD), your doctor has probably told you there isn't much they can do for you. Mainstream medicine doesn't have a cure for CKD. What they do have is a lot of drugs to [Read More]

DEADLINE EXTENDED UNTIL DEC. 19: Enroll In or Change Plans for Health Insurance Marketplace Coverage

DEADLINE EXTENDED UNTIL DEC. 19: Enroll In or Change Plans for Health Insurance Marketplace Coverage

Original post:   DEADLINE EXTENDED UNTIL DEC. 19: Enroll In or Change Plans for Health Insurance Marketplace Coverage [Read More]

Last Day for Health Insurance Marketplace Coverage that starts Jan. 1, 2017

Last Day for Health Insurance Marketplace Coverage that starts Jan. 1, 2017

/About-the-Society/News/2016openenrollment [Read More]

 Page 1 of 14  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]